Home › Funds › Commodore Capital LP › ATOS
Commodore Capital LP position in ATOS
ATOSSA THERAPEUTICS INC · Health Care
Commodore Capital LP reported holding 1,160,000 shares of ATOS (ATOSSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$19.9M, representing 1.54% of its reported portfolio and ranking #20 among its reported holdings. Commodore Capital LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Commodore Capital LP's ATOS position evolved
Commodore Capital LP first disclosed a stake in ATOS in Q3 2026 at 1,160,000 shares (US$19.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.16M | $19.88M | New |
About ATOS and 13F data
ATOS (ATOSSA THERAPEUTICS INC) is a Health Care company. 62 other funds we track also report a position in ATOS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$120.8M), venBio Partners LLC (US$71.7M), Deep Track Capital, LP (US$55.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ATOS
- Frazier Life Sciences Management, L.P. 7.05M sh · $120.77M · Q3 2026
- venBio Partners LLC 4.18M sh · $71.67M · Q3 2026
- Deep Track Capital, LP 3.21M sh · $54.97M · Q3 2026
- EcoR1 Capital, LLC 2.02M sh · $34.69M · Q3 2026
- Nextech Invest Ltd. 1.84M sh · $31.45M · Q3 2026
- Cormorant Asset Management, LP 1.79M sh · $30.66M · Q3 2026
- Redmile Group, LLC 1.16M sh · $19.94M · Q3 2026
- Sanofi 1.08M sh · $18.56M · Q3 2026
- Vivo Capital, LLC 300.00K sh · $5.14M · Q3 2026
- Spruce Street Capital LP 228.29K sh · $3.91M · Q3 2026
- Kalehua Capital Management LLC 200.00K sh · $3.43M · Q3 2026
- Boxer Capital Management, LLC 200.00K sh · $3.43M · Q3 2026
More on Commodore Capital LP
FAQ
How long has Commodore Capital LP held ATOS?
Commodore Capital LP has disclosed ATOS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Commodore Capital LP's current position in ATOS?
As of Q3 2026, Commodore Capital LP holds 1.16M shares of ATOS (ATOSSA THERAPEUTICS INC), valued at $19.88M, representing 1.54% of its reported portfolio and ranking #20.
Has Commodore Capital LP been buying or selling ATOS?
In the latest 13F filing (Q3 2026), Commodore Capital LP newly opened its position in ATOS.
Which other funds hold ATOS?
Other major institutional holders of ATOS include Frazier Life Sciences Management, L.P., venBio Partners LLC, Deep Track Capital, LP, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.